Just saw MannKind announced Lauren Sabella stepping down from her role. She was brought in as EVP of Operations back in early 2025 but apparently decided to call it quits by mid-year. Interesting timing for a pharma company to have leadership shifts like this. The stock's been pretty flat YTD anyway, so not sure if this moves the needle much. Lauren Sabella's departure doesn't seem to be triggering any major market reaction based on what I'm seeing. Market cap sitting around 1.79B, trading volume looks normal. Curious if there's more context to this or if it's just a planned transition. Anyone else tracking MNKD?

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin